#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy The Netherlands Spain

  • Study on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain

  • Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Italy

  • Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

    Recruiting

    3 1
    Investigated Drugs:
    Belgium Denmark Germany Italy Spain

  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark Germany Italy Spain

  • Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

    Recruiting

    3 1 1
    Investigated Drugs:
    France

  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    1 1
    Investigated Drugs:
    France Italy The Netherlands Spain

  • Study on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain

  • A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy Spain